Virus particle binding

The term "virus particle binding" refers to the process by which a virus initiates infection by attaching to specific receptors on the surface of a susceptible host cell[1][2][3][6][7]. This attachment is highly specific, typically involving viral surface proteins and particular host cell molecules such as proteins, carbohydrates, or lipids. Virus particle binding is the first step in the viral life cycle, enabling subsequent entry into the host cell through membrane fusion or endocytosis. Because many viruses use distinct and specific host cell receptors (e.g., CD4 for HIV, ACE2 for SARS-CoV-2), "virus particle binding" does not define a single molecule or druggable target, but rather a biological interaction fundamental to viral infection and pathogenesis[1][2][3][4][6][7]. Key issues: - "Virus particle binding" is not a molecule or defined receptor, but a description of a process involving multiple different molecular targets depending on the virus species. - This entry would require correction or specification to a defined receptor (e.g., "Angiotensin-converting enzyme 2" for SARS-CoV-2, "CD4" for HIV-1, etc.) to be meaningful in a therapeutic target database[1][2][3][6][7].

Other names

virus-host bindingvirus attachmentviral entry